According to the new market research “Cardiac Surgery Instruments Market by Product (Clamps, Forceps, Scalpel, Scissors, Needle Holder), Application (Coronary Artery Bypass Graft, Heart Valve Surgery, Pediatric Surgery, Heart Transplant), & End User (Hospital, ASC) – Global Forecast to 2022″ published by MarketsandMarkets, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and Rest of the World (RoW)
Don’t miss out on business opportunities in Cardiac Surgery Instruments Market.
Speak to our analyst and gain crucial industry insights that will help your business grow:
The global cardiac surgery instruments market is expected to reach USD 1.63 Billion by 2022 from USD 1.16 Billion in 2017, at a CAGR of 7.1%. The growth of the market is mainly driven by factors such as growing prevalence of cardiac conditions and subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide. However, adoption of alternative surgical methods and lack of Medicare payments are the major factors that may restrain the growth of this market to a certain extent during the forecast period.
The report segments the market based on products, applications, end user, and region. Based on products, the market is segmented into forceps, scissors, needle holders, clamps, and other cardiac surgery instruments. Forceps are expected to account for the largest share of the market, in 2017. The growth of the forceps segment is attributed to the increase in the number of cardiac surgery procedures and the repeated use of forceps in most surgeries.
Based on application, the market is further segmented into coronary artery bypass graft (CABG), heart valve surgery, pediatric cardiac surgery, and other applications. CABG segment is expected to grow at the highest CAGR during the forecast period. CABG forms the largest and fastest-growing application segment of the market. This is mainly attributed to the high incidence of cardiac diseases and resulting increase in the number of surgical procedures.
Browse and in-depth TOC on “Cardiac Surgery Instruments Market”
82 – Tables
34 – Figures
150 – Pages
Request for Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=162566843
Based on region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest share of this market in 2017. However, the Asian market is expected to grow at the highest CAGR mainly due to the increasing awareness programs, high incidence of cardiac diseases, rising funding for cardiac research, and improvements in the healthcare sector of Asian countries.
Early buyers will receive 10% customization on reports – https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=162566843
The global cardiac surgery equipment market is dominated by North America, followed by Europe. The market in Asia is expected to grow at the highest CAGR during the forecast period. Factors such as increasing awareness programs, high incidence of cardiac diseases, rising number of hospitals, increased cardiac research funding, and improvements in the healthcare sector of Asian countries contribute to the growth of the market in that region.
Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG (Germany), Teleflex Incorporated (U.S.), Medline Industries, Inc. (U.S.), KLS Martin Group (U.S.), Stille (Sweden), Sklar Surgical Instruments (U.S.), Symmetry Surgical Inc. (U.S.), Delacroix-Chevalier (France), Wexler Surgical (U.S.), Surgins (U.K.), Surtex Instruments Ltd. (U.K.), Cardivon Surgical Inc. (China), Rumex International Corporation (U.S.), and Scanlan International (U.S.).